CPJE PRACTICE EXAM 2026 NEWEST ACTUAL EXAM –
COMPREHENSIVE PRACTICE TEST |FREQUENTLY TESTED
QUESTIONS WITH VERIFIED CORRECT ANSWERS AND DETAILED
RATIONALES |CALIFORNIA PRACTICE STANDARDS AND
JURISPRUDENCE EXAM LATEST UPDATE
UNIT 1: CALIFORNIA PHARMACY LAW AND JURISPRUDENCE (1–55)
1. A pharmacist's license expires on the last day of which month?
a) January
b) The pharmacist's birth month
c) June
d) December
Answer: b
Rationale: A pharmacist's license expires on the last day of the pharmacist's
birth month. Renewal must be completed prior to that date to avoid late fees or
lapse. This is a California-specific requirement under the Business and
Professions Code. Options (a), (c), and (d) are incorrect because they do not
reflect California's birth-month renewal cycle.
2. What is the primary legislative purpose of the California Board of Pharmacy?
a) To promote the interests of pharmacists
b) To protect the health, safety, and welfare of the people of California
c) To regulate the price of prescription drugs
d) To license all healthcare professionals
Answer: b
Rationale: The Board's primary mandate is public protection, not professional
advocacy. Protecting the public is the highest priority for the California
Board of Pharmacy. Option (a) is incorrect because the Board does not exist to
promote pharmacist interests. Option (c) is incorrect because drug pricing is
not the Board's primary function. Option (d) is incorrect because the Board
licenses pharmacy professionals, not all healthcare professionals.
3. How soon must a pharmacy notify the California State Board of Pharmacy of
the
establishment of drug take-back services?
1
,a) 14 days
b) 30 days
c) 7 days
d) Immediately
Answer: b
Rationale: The board must be notified within 30 days of establishing drug
take-back services. This requirement ensures the Board can track and regulate
drug disposal programs. Options (a), (c), and (d) are incorrect timeframes.
4. How soon must a pharmacy report to the Board when a licensed individual is
employed or terminated?
a) Within 7 days
b) Within 14 days
c) Within 30 days
d) Within 45 days
Answer: b
Rationale: The pharmacy must report to the board within 14 days of the receipt
of information or development regarding any licensed individual employed by or
with the pharmacy. This includes both hiring and termination. Options (a), (c),
and (d) are incorrect.
5. What are the name tag requirements for pharmacy personnel in California?
a) Name tag must display name only in 12-point type
b) Name tag is optional for technicians
c) Only pharmacists are required to wear name tags
d) Name tag must display name and license status in 18-point type (minimum)
Answer: d
Rationale: All pharmacists, interns, pharmacy technicians, and technician
trainees must wear name tags while on duty. The name tag must display their
name and license status in 18-point type (minimum). Options (a), (b), and (c)
are incorrect because they misstate the requirements.
6. How many interns may a pharmacist supervise at one time?
a) 1 intern
b) 2 interns
2
,c) 3 interns
d) 4 interns
Answer: b
Rationale: A pharmacist may supervise up to two interns at any one time. This
limit ensures adequate supervision and training. Options (a), (c), and (d) are
incorrect.
7. What is the pharmacy technician ratio when only one pharmacist is on duty?
a) 1 pharmacist: 1 technician
b) 1 pharmacist: 2 technicians
c) 1 pharmacist: 3 technicians
d) 1 pharmacist: 4 technicians
Answer: a
Rationale: When only one pharmacist is present, the ratio is 1 pharmacist to 1
technician. This ensures patient safety and adequate supervision. Options (b),
(c), and (d) are incorrect because they exceed the permitted ratio.
8. Under California law (B&P Section 4113.1), a pharmacy must maintain records
of medication error reports for how long?
a) 1 year
b) 2 years
c) 3 years
d) 5 years
Answer: c
Rationale: B&P §4113.1 requires that medication error reports be maintained for
3 years. This allows for tracking and quality improvement. Options (a), (b),
and (d) are incorrect retention periods.
9. What is the effective date of the requirement under AB 1503 that a
nonresident pharmacy must designate a California-licensed pharmacist as its
pharmacist-in-charge (PIC)?
a) January 1, 2025
b) July 1, 2026
c) January 1, 2027
d) January 1, 2030
3
, Answer: b
Rationale: AB 1503, signed into law on October 1, 2025, requires that beginning
July 1, 2026, each nonresident pharmacy must identify a California-licensed
pharmacist employed at that pharmacy to serve as its PIC. This applies even if
the pharmacy's physical operations are entirely outside California. Options
(a), (c), and (d) are incorrect.
10. Under SB 41, which of the following is prohibited in PBM contracts issued,
amended, or renewed on or after January 1, 2026?
a) Spread pricing
b) Flat pharmacy benefit management fees
c) Rebate pass-through to payers
d) Prior authorization for brand-name drugs
Answer: a
Rationale: SB 41 prohibits spread pricing (where a PBM charges a plan more than
it reimburses the pharmacy and keeps the difference) and mandates a
pass-through pricing model effective January 1, 2026. Options (b), (c), and (d)
are not prohibited by SB 41.
11. When must a nonresident pharmacy, under AB 1503, notify the California
State
Board of Pharmacy of a change in its designated PIC?
a) Within 7 days of the change
b) Within 30 days of the change
c) Within 14 days of the change
d) Immediately upon the change
Answer: b
Rationale: Under AB 1503, nonresident pharmacies must notify the Board of
changes in PIC within 30 days. The standard reporting period for such changes
aligns with general licensing requirements. Options (a), (c), and (d) are
incorrect.
12. A pharmacist receives a prescription for a Schedule II medication with no
prescriber signature. What is the appropriate action?
a) Dispense the medication as written
4
COMPREHENSIVE PRACTICE TEST |FREQUENTLY TESTED
QUESTIONS WITH VERIFIED CORRECT ANSWERS AND DETAILED
RATIONALES |CALIFORNIA PRACTICE STANDARDS AND
JURISPRUDENCE EXAM LATEST UPDATE
UNIT 1: CALIFORNIA PHARMACY LAW AND JURISPRUDENCE (1–55)
1. A pharmacist's license expires on the last day of which month?
a) January
b) The pharmacist's birth month
c) June
d) December
Answer: b
Rationale: A pharmacist's license expires on the last day of the pharmacist's
birth month. Renewal must be completed prior to that date to avoid late fees or
lapse. This is a California-specific requirement under the Business and
Professions Code. Options (a), (c), and (d) are incorrect because they do not
reflect California's birth-month renewal cycle.
2. What is the primary legislative purpose of the California Board of Pharmacy?
a) To promote the interests of pharmacists
b) To protect the health, safety, and welfare of the people of California
c) To regulate the price of prescription drugs
d) To license all healthcare professionals
Answer: b
Rationale: The Board's primary mandate is public protection, not professional
advocacy. Protecting the public is the highest priority for the California
Board of Pharmacy. Option (a) is incorrect because the Board does not exist to
promote pharmacist interests. Option (c) is incorrect because drug pricing is
not the Board's primary function. Option (d) is incorrect because the Board
licenses pharmacy professionals, not all healthcare professionals.
3. How soon must a pharmacy notify the California State Board of Pharmacy of
the
establishment of drug take-back services?
1
,a) 14 days
b) 30 days
c) 7 days
d) Immediately
Answer: b
Rationale: The board must be notified within 30 days of establishing drug
take-back services. This requirement ensures the Board can track and regulate
drug disposal programs. Options (a), (c), and (d) are incorrect timeframes.
4. How soon must a pharmacy report to the Board when a licensed individual is
employed or terminated?
a) Within 7 days
b) Within 14 days
c) Within 30 days
d) Within 45 days
Answer: b
Rationale: The pharmacy must report to the board within 14 days of the receipt
of information or development regarding any licensed individual employed by or
with the pharmacy. This includes both hiring and termination. Options (a), (c),
and (d) are incorrect.
5. What are the name tag requirements for pharmacy personnel in California?
a) Name tag must display name only in 12-point type
b) Name tag is optional for technicians
c) Only pharmacists are required to wear name tags
d) Name tag must display name and license status in 18-point type (minimum)
Answer: d
Rationale: All pharmacists, interns, pharmacy technicians, and technician
trainees must wear name tags while on duty. The name tag must display their
name and license status in 18-point type (minimum). Options (a), (b), and (c)
are incorrect because they misstate the requirements.
6. How many interns may a pharmacist supervise at one time?
a) 1 intern
b) 2 interns
2
,c) 3 interns
d) 4 interns
Answer: b
Rationale: A pharmacist may supervise up to two interns at any one time. This
limit ensures adequate supervision and training. Options (a), (c), and (d) are
incorrect.
7. What is the pharmacy technician ratio when only one pharmacist is on duty?
a) 1 pharmacist: 1 technician
b) 1 pharmacist: 2 technicians
c) 1 pharmacist: 3 technicians
d) 1 pharmacist: 4 technicians
Answer: a
Rationale: When only one pharmacist is present, the ratio is 1 pharmacist to 1
technician. This ensures patient safety and adequate supervision. Options (b),
(c), and (d) are incorrect because they exceed the permitted ratio.
8. Under California law (B&P Section 4113.1), a pharmacy must maintain records
of medication error reports for how long?
a) 1 year
b) 2 years
c) 3 years
d) 5 years
Answer: c
Rationale: B&P §4113.1 requires that medication error reports be maintained for
3 years. This allows for tracking and quality improvement. Options (a), (b),
and (d) are incorrect retention periods.
9. What is the effective date of the requirement under AB 1503 that a
nonresident pharmacy must designate a California-licensed pharmacist as its
pharmacist-in-charge (PIC)?
a) January 1, 2025
b) July 1, 2026
c) January 1, 2027
d) January 1, 2030
3
, Answer: b
Rationale: AB 1503, signed into law on October 1, 2025, requires that beginning
July 1, 2026, each nonresident pharmacy must identify a California-licensed
pharmacist employed at that pharmacy to serve as its PIC. This applies even if
the pharmacy's physical operations are entirely outside California. Options
(a), (c), and (d) are incorrect.
10. Under SB 41, which of the following is prohibited in PBM contracts issued,
amended, or renewed on or after January 1, 2026?
a) Spread pricing
b) Flat pharmacy benefit management fees
c) Rebate pass-through to payers
d) Prior authorization for brand-name drugs
Answer: a
Rationale: SB 41 prohibits spread pricing (where a PBM charges a plan more than
it reimburses the pharmacy and keeps the difference) and mandates a
pass-through pricing model effective January 1, 2026. Options (b), (c), and (d)
are not prohibited by SB 41.
11. When must a nonresident pharmacy, under AB 1503, notify the California
State
Board of Pharmacy of a change in its designated PIC?
a) Within 7 days of the change
b) Within 30 days of the change
c) Within 14 days of the change
d) Immediately upon the change
Answer: b
Rationale: Under AB 1503, nonresident pharmacies must notify the Board of
changes in PIC within 30 days. The standard reporting period for such changes
aligns with general licensing requirements. Options (a), (c), and (d) are
incorrect.
12. A pharmacist receives a prescription for a Schedule II medication with no
prescriber signature. What is the appropriate action?
a) Dispense the medication as written
4
